Earnings · China A-shares
MedicalSystem Biotechnology Co., Ltd. Class A (300439) earnings
MedicalSystem Biotechnology Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit +61.62% year on year, +157.49% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +4.29% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- +61.62%
- Excl. one-offs YoY
- +157.49%
- Net profit QoQ
- +27.34%
- Result
- Great
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +10.33% | — |
| 3 days | +4.29% | — |
| 7 days | +9.12% | — |
| 14 days | +3.85% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 4 of 7 reports (average +0.17%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | ¥97.84M | +61.62% | +157.49% | +12.22% | 0.25 | 3.26% | +4.29% | — | — |
| 2026 interim report | 2026-08-29 | ¥61.95M | +9.00% | +47.34% | +12.47% | 0.16 | 2.08% | +0.32% | +1.28% | +10.61% |
| 2026 Q1 report | 2026-04-29 | ¥33.77M | +11.08% | +12.09% | +0.53% | 0.09 | 1.14% | +5.49% | -10.77% | -11.71% |
| 2025 annual report | 2026-04-29 | ¥63.20M | -75.50% | -92.99% | -11.67% | 0.16 | 2.15% | +5.49% | -10.77% | -11.71% |
| 2025 Q3 report | 2025-10-29 | ¥60.53M | -73.02% | -83.86% | -19.27% | 0.16 | 2.05% | -0.86% | -2.85% | +0.62% |
| 2025 interim report | 2025-08-29 | ¥56.83M | -68.15% | -80.03% | -22.43% | 0.15 | 1.92% | -1.73% | -7.28% | -8.55% |
| 2025 Q1 report | 2025-04-26 | ¥30.40M | -61.57% | -68.11% | -22.32% | 0.08 | 1.03% | -7.24% | -2.93% | -6.18% |
| 2024 annual report | 2025-04-19 | ¥258.00M | +0.56% | +12.67% | -7.61% | 0.67 | 9.14% | +0.90% | -5.96% | -8.91% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.